CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 205 filers reported holding CHEMOCENTRYX INC in Q3 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,390,000 | +118.7% | 46,272 | +5.0% | 0.00% | +200.0% |
| Q2 2022 | $1,093,000 | -63.7% | 44,089 | -63.2% | 0.00% | -66.7% |
| Q1 2022 | $3,007,000 | +29.6% | 119,945 | +88.2% | 0.00% | +50.0% |
| Q4 2021 | $2,320,000 | +248.3% | 63,718 | +63.5% | 0.00% | +100.0% |
| Q3 2021 | $666,000 | +10.3% | 38,966 | -13.6% | 0.00% | 0.0% |
| Q2 2021 | $604,000 | -73.6% | 45,120 | +0.9% | 0.00% | -66.7% |
| Q1 2021 | $2,290,000 | -17.3% | 44,700 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,768,000 | +18.6% | 44,700 | +4.9% | 0.00% | 0.0% |
| Q3 2020 | $2,334,000 | -0.6% | 42,600 | +4.4% | 0.00% | 0.0% |
| Q2 2020 | $2,348,000 | +58.8% | 40,800 | +10.9% | 0.00% | +50.0% |
| Q1 2020 | $1,479,000 | +1.6% | 36,800 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,455,000 | +416.0% | 36,800 | -11.5% | 0.00% | – |
| Q3 2019 | $282,000 | -27.1% | 41,600 | 0.0% | 0.00% | – |
| Q2 2019 | $387,000 | +9.6% | 41,600 | +63.8% | 0.00% | – |
| Q1 2019 | $353,000 | +27.4% | 25,400 | 0.0% | 0.00% | – |
| Q4 2018 | $277,000 | -13.7% | 25,400 | 0.0% | 0.00% | – |
| Q3 2018 | $321,000 | -33.3% | 25,400 | -30.4% | 0.00% | -100.0% |
| Q2 2018 | $481,000 | -4.8% | 36,500 | -1.6% | 0.00% | 0.0% |
| Q1 2018 | $505,000 | +128.5% | 37,100 | 0.0% | 0.00% | – |
| Q4 2017 | $221,000 | -30.3% | 37,100 | -13.2% | 0.00% | – |
| Q3 2017 | $317,000 | -8.6% | 42,764 | +15.3% | 0.00% | – |
| Q2 2017 | $347,000 | +85.6% | 37,100 | +44.4% | 0.00% | – |
| Q1 2017 | $187,000 | +16.9% | 25,701 | +19.0% | 0.00% | – |
| Q4 2016 | $160,000 | +154.0% | 21,600 | +105.7% | 0.00% | – |
| Q3 2016 | $63,000 | +34.0% | 10,500 | 0.0% | 0.00% | – |
| Q2 2016 | $47,000 | -25.4% | 10,500 | -58.8% | 0.00% | – |
| Q1 2016 | $63,000 | -69.6% | 25,500 | 0.0% | 0.00% | – |
| Q4 2015 | $207,000 | +34.4% | 25,500 | 0.0% | 0.00% | – |
| Q3 2015 | $154,000 | -39.4% | 25,500 | -17.3% | 0.00% | – |
| Q2 2015 | $254,000 | – | 30,840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
| Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
| HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
| Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
| Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
| Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
| Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
| Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
| Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |